From P-values to Patient Values:

MDIC to Reveal Patient-Generated P-Values from Parkinson’s Patient Preference Study

In September 2016, MDIC launched a new initiative in patient-centered clinical trials.

With CDRH, the Michael J. Fox Foundation for Parkinson’s Research, MIT, and RTI Health Solutions, we developed and tested a novel method for incorporating patient preference information as an explicit means to set significance levels in clinical trial design.

Setting patient- and therapy-specific significance levels may be a pathway to treatment access for patients with a higher risk tolerance and no effective therapies.

On May 18, 2018, at the Westin Arlington Gateway in Arlington, VA, we are pleased to present the results, implications, and next steps for this initiative. Download the agenda here.

Reports from the May 18 workshop

Workshop Summary: MDIC PCOR Project: From P-Values to Patient Values in Parkinson’s Disease

Guest article in Medical Device Online: The Science Of Patient Preferences In Med Device Clinical Trial Design

Slides and summaries from the May 18 workshop

Videos from the workshop

To learn more about the project visit Science of Patient Input or contact MDIC Science of Patient Input (SPI) Program Director, Stephanie Christopher at